Medical/Pharmaceuticals
EBT Medical and NinaMED Announce US$13.75M Financing to Advance Licensed NiNA System® for Overactive Bladder
* US$13.75M financing completed to accelerate clinical pathway and global commercialisation * Establishment of NinaMED Pty Ltd, a new Australian medtech company * NinaMED Pty Ltd secures a license from EBT Medical for exclusive global rights to NiNA System®, a non‑invasive, at‑home OAB thera...
2026-05-14 13:03
2882
Singapore's First Immersive Installation on the Cycles of Intergenerational Harm Opens at One Punggol This May
Why Hurt Children Hurt Children invites Singaporeans to step inside The Black Box — a confrontational, compassionate experience addressing the emotional harm that passes silently from one generation to the next SINGAPORE, May 14, 2026 /PRNewswire/ -- EveryChild.SG, Singapore's movement for child...
2026-05-14 12:11
3841
MEDIPOST's CARTISTEM® Meets All Primary and Secondary Endpoints in Japan Phase 3 Trial and Demonstrates Statistically Significant Efficacy Gains Versus Active Control
- Achieved statistical significance versus standard-of-care (SOC) control across all key efficacy endpoints in the 52-week study - Japan Phase 3 results strengthen CARTISTEM's® global commercial prospects, with Japan biologics license application (BLA) scheduled for 2H 2026 SEOUL, South Korea and...
2026-05-14 10:30
3831
METiS TechBio, the World's First Publicly Listed AI-Powered Drug Delivery Company, Debuts on the Hong Kong Stock Exchange, "The SpaceX of Pharmaceuticals" Ushers in a New Era of Biopharmaceuticals
HONG KONG, May 13, 2026 /PRNewswire/ -- METiS TechBio (7666.HK), a tech-bio company focused on AI-powered nanodelivery innovation, today successfully listed on the Hong Kong Stock Exchange (HKEX), becoming the world's first publicly listed AI-powered drug delivery company and the first AI-powered...
2026-05-14 10:09
3997
Corti steps up its support for the next wave of healthcare startups as OpenAI pushes into the space and others retreat from Europe
As compliance pressure mounts in every major healthcare AI market, Corti launches its Startup Acceleration Program to help founders clear a €600,000 regulatory barrier and build on the vertical model that outscored OpenAI on its new healthcare benchmark COPENHAGEN, Denmark, May 14, 2026 /PRNewsw...
2026-05-14 00:30
3340
Elabscience® Launches Self-Developed PolyHRP-Streptavidin Conjugate for Low-Abundance Biomarker Detection in ELISA
HOUSTON, May 13, 2026 /PRNewswire/ -- Elabscience® Bionovation Inc. ("Elabscience®" or "the Company") today announced the launch of its self-developed PolyHRP-Streptavidin conjugate, a signal amplification reagent designed to improve enzyme-linked immunosorbent assay (ELISA) sensitivity for low-...
2026-05-14 00:00
3120
Piramal Pharma Solutions Unveils State-of-the-Art Payload-Linker Suite at its Riverview, Michigan Facility
* The Riverview facility provides comprehensive services for active pharmaceutical ingredients (APIs) and high potency APIs (HPAPIs), including specialized solutions for payload-linkers. * This cutting-edge suite will significantly enhance the company's ability to support global payload-linke...
2026-05-13 22:45
3493
ZEISS expands ophthalmic surgical workflows in Mexico with COFEPRIS approval for ARTEVO 850 and MICOR 700
* Elevates digital visualization for surgeons - ZEISS ARTEVO 850 surgical microscope provides ophthalmic surgeons in Mexico with advanced 3D visualization and end-to-end workflow integration. * Minimizes risk and increases O.R. efficiency for cataract surgery - ZEISS MICOR 700 first hand-held...
2026-05-13 21:00
3155
NYSE Content Update: Global Medical Response to Go Public After $479 Million IPO
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, May 13, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins...
2026-05-13 20:59
4376
Department of Health - Abu Dhabi and Fred Hutchinson Cancer Center collaborate on cancer research and personalized prevention
ABU DHABI, UAE, May 13, 2026 /PRNewswire/ -- The Department of Health - Abu Dhabi (DoH), regulator of the healthcare sector in the emirate, together with the Abu Dhabi Public Health Center (ADPHC), today announced the execution of a Memorandum of Understanding ("MOU") with Fred Hutchinson Cancer ...
2026-05-13 20:23
3400
High-Trend International Group Announces Pricing of $15 Million Registered Direct Offering with Global Institutional Investors
NEW YORK, May 13, 2026 /PRNewswire/ -- High-Trend International Group (NASDAQ: HTCO) ("HTCO" or the "Company"), a global ocean transportation company, today announced that it has entered into securities purchase agreements with global institutional investors for the purchase and sale of 2,307,700...
2026-05-13 20:00
4437
Synnovis and SOPHiA GENETICS Partner to Bring Blood-based Cancer Testing to Patients Across the U.K.
LONDON, May 13, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ: SOPH), a global leader in Ai-driven precision medicine, today announced a partnership with Synnovis, one of England's leading pathology providers, to bring liquid biopsy testing to lung and breast cancer patients across the U.K. as par...
2026-05-13 17:00
2836
Getting a leg up on diabetic lower limb amputation with new AI risk prediction model
SINGAPORE, May 13, 2026 /PRNewswire/ -- Personalised risk-based monitoring may soon be the norm for patients with diabetes at high risk of lower extremity amputation (LEA). Jointly developed by Singapore General Hospital (SGH), SingHealth, and the MOH Office for Healthcare Transformation (MOHT), ...
2026-05-13 16:55
2698
New Survey Reveals that Singaporeans Know More about Dementia But Nearly 7 in 10 are Unsure Where to Seek Help
Third national survey by SMU on dementia found that stigma persists; despite rising awareness, preparedness remains below neutral SINGAPORE, May 13, 2026 /PRNewswire/ -- Singaporeans are significantly more aware of dementia than they were five years ago, but most still do not know where to turn ...
2026-05-13 16:11
4651
THE ADECCO GROUP Q1 2026 RESULTS
Strong revenue growth, share gains and improved profitability, supported by rigorous execution ZURICH, Switzerland, May 13, 2026 /PRNewswire/ -- AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange HIGHLIGHTS * Accelerating organic revenue growth of +5.3% TDA yoy * Co...
2026-05-13 12:45
3142
New Nature Communications Publication Highlights Efsubaglutide Alfa's Effects on Glycaemia and β-Cell Function
HONG KONG, May 12, 2026 /PRNewswire/ -- A major new clinical study, SUPER 2, has been published in Nature Communications, reporting that Efsubaglutide Alfa, a long-actingGLP-1 receptor agonist, significantly improved glycaemic control in adults with type 2 diabetes inadequately controlled on metf...
2026-05-13 11:47
3335
WuXi Biologics Included in 2026 Dow Jones Best‑in‑Class World Index and Emerging Markets Index
SHANGHAI, May 12, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that, in recognition of its continued efforts and exceptional performance in advancing sustainability, the Company has been included i...
2026-05-13 11:33
3976
Innovent to Present Multiple Clinical and Preclinical Results of Mazdutide and Next-Generation Obesity & Metabolic Pipeline at the 2026 ADA Scientific Sessions
SAN FRANCISCO and SUZHOU, China, May 12, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...
2026-05-13 08:00
4378
Kelun-Biotech Receives Investigational New Drug Approval from CDE for SKB118, a PD-1 x VEGF Bispecific Antibody
CHENGDU, China, May 12, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that it has received a clinical trial notice from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) appro...
2026-05-13 08:00
4670
GenScript Launches TurboCHO™ Protein Expression Kit, Delivering the Fastest Path to Antibodies in its Class
New kit offers researchers and development teams a meaningful advance in
expression speed and output
BOSTON, May 13, 2026 /PRNewswire/ -- GenScript Biotech Corporation
2026-05-13 00:19
3341
Week's Top Stories
Most Reposted
Asia Pacific Travellers Seek Familiarity, Practicality, Flexibility Amid Shifting Global Dynamics: Visa Report
[Picked up by 324 media titles]
2026-06-16 10:00
Visa and Mintoak Join Forces to Bring Merchant SaaS Capabilities to Acquirers Across Asia Pacific
[Picked up by 312 media titles]
2026-06-17 11:00Visa Partners with OpenAI to Power the Next Generation of AI Commerce
[Picked up by 306 media titles]
2026-06-11 09:30QuettaFlow Technologies Strengthens Global Strategic Alliance with Lead Wealth and Showcases VasEdge at COMPUTEX Taipei 2026
[Picked up by 296 media titles]
2026-06-11 10:00
Rediscover the Art of Gathering with the Luxury Group by Marriott International
[Picked up by 290 media titles]
2026-06-16 11:00
Most Read
Visa Partners with OpenAI to Power the Next Generation of AI Commerce
2026-06-11 09:30
9456
51Talk Online Education Group Announces First Quarter 2026 Results
2026-06-12 19:00
9365
NYSE Content Update: Fifth Third Bancorp Celebrates Historic Listing Transfer
2026-06-12 21:08
8610
